- Previous Close
2,888.00 - Open
2,838.00 - Bid --
- Ask --
- Day's Range
2,747.00 - 2,925.00 - 52 Week Range
2,116.00 - 3,165.00 - Volume
5,200 - Avg. Volume
2,940 - Market Cap (intraday)
7.139B - Beta (5Y Monthly) 0.43
- PE Ratio (TTM)
16.39 - EPS (TTM)
176.60 - Earnings Date Mar 31, 2025
- Forward Dividend & Yield 122.00 (4.21%)
- Ex-Dividend Date May 29, 2025
- 1y Target Est
--
Yamashita Health Care Holdings,Inc. engages in the supply of medical equipment in Japan. The company offers diagnostic imaging devices, such as MRI and CT, endoscopic systems, operating tables, and surgical equipment comprising electric scalpels, orthopedic implants, various catheters, and disposable medical materials; plans, manufactures, consigns, imports, and sells implants that are embedded in the body in the field of orthopedics; and sells and maintains medical equipment, which include dialysis machines/dialysis consumables, peritoneal dialysis, and stents. It also provides consulting services related to the management of medical and nursing care institutions; and develops reservation solutions for hospitals consisting of search portal sites for hospitals and clinics, online reception, posting agency for customer satisfaction surveys, and network security systems sales. The company was founded in 1926 and is headquartered in Fukuoka City, Japan.
www.yhchd.co.jpRecent News: 9265.T
View MorePerformance Overview: 9265.T
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 9265.T
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 9265.T
View MoreValuation Measures
Market Cap
7.14B
Enterprise Value
2.62B
Trailing P/E
16.38
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.11
Price/Book (mrq)
0.82
Enterprise Value/Revenue
0.04
Enterprise Value/EBITDA
2.67
Financial Highlights
Profitability and Income Statement
Profit Margin
0.94%
Return on Assets (ttm)
2.17%
Return on Equity (ttm)
6.97%
Revenue (ttm)
63.73B
Net Income Avi to Common (ttm)
599M
Diluted EPS (ttm)
176.60
Balance Sheet and Cash Flow
Total Cash (mrq)
4.1B
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--